Faron Pharmaceuticals moving "into next phase" with new CFO | News Direct

Faron Pharmaceuticals moving "into next phase" with new CFO

Faron Pharmaceuticals Oy
News release by Faron Pharmaceuticals Oy

facebook icon linkedin icon twitter icon pinterest icon email icon London, UK | April 06, 2023 05:27 AM Eastern Daylight Time

 

Faron Pharmaceuticals Limited (AIM:FARN, OTC:FPHAF) chief financial officer James O'Brien speaks to Proactive on his second day in the new role.

 

O'Brien reveals more about what he believes he can bring to Faron, highlighting his experience in the US capital markets.

 

He adds that Faron is now moving "into [its} next phase of growth."

 

Contact Details

 

Proactive UK Ltd

 

+44 20 7989 0813

 

uk@proactiveinvestors.com

project media

Tags

HealthPharmaceuticalbiopharmaceuticalimmune systemBexmarilimab